Other News
GSK announces new strategic investments in Africa to increase access to medicines, build capacity and deliver sustainable growth
…Creates world’s first R&D Open Lab to increase understanding of non-communicable diseases and support development of new medicines for Africa
…Significantly increases African manufacturing presence to build capacity and enhance regional self sufficiency
…Establishes 25 academic Chairs at African universities to support development of local skills and capabilities in science, engineering, public health and other related areas
…Commits to train an additional 10,000 community healthworkers across sub-Saharan Africa
LONDON – GSK today announced a series of new investments in sub-Saharan Africa designed to address pressing health needs and contribute to long-term business growth.
Speaking at the 5th EU-Africa Business Forum in Brussels, GSK CEO Sir Andrew Witty set out the company’s intent to partner with governments of African countries to help stimulate more research into chronic diseases, increase capacity by localising medicines supply and strengthen healthcare infrastructure.
This will see GSK make targeted investments of up to £130 million in Africa over the next five years, creating at least 500 jobs and contributing to the development of home-grown capabilities and skills in Africa. This builds on GSK’s existing business base in sub-Saharan Africa, which currently employs around 1,500 people in over 40 countries, including at three existing local manufacturing sites in Kenya, Nigeria and South Africa.
Speaking at the meeting, Andrew Witty said: “Today, we are setting out further steps to tackle Africa’s dual health burden of infectious and emerging non-communicable diseases and help build crucial capacity to underpin the development of the healthcare sector in the region. We have a unique opportunity to deliver meaningful social and economic value to all of the communities we work in – using our scientific expertise and our global reach to develop innovative medicines and deliver them to people who need them around the world.
“With global attention focused on how we support development beyond 2015, now is the moment for business to play a more active role in contributing to a more prosperous future in Africa, investing in infrastructure, building skills and capability to unlock human potential and create jobs. Our long-term goal is to equip Africa to discover, develop and produce the medicines required for Africa.”
Supporting the development of new medicines for Africa
GSK will invest £25 million to create the world’s first R&D Open Lab for non-communicable diseases (NCDs) in Africa. This builds on the success of GSK’s Open Lab in Tres Cantos, Spain which gives independent researchers access to GSK facilities, resources and knowledge to help them advance their own research projects into diseases of the developing world such as malaria, tuberculosis and leishmaniasis.
The new R&D Open Lab for NCDs in Africa will see GSK scientists collaborate with research and scientific centres across Africa from its hub at GSK’s Stevenage R&D facility in the UK to conduct high quality epidemiological, genetic and interventional research to increase understanding of NCDs in Africa. An independent governing board of leading scientists and clinicians will oversee the implementation of NCD research projects within a dynamic and networked open innovation environment.
The open lab aims to improve understanding of NCD variations seen in the Africa setting, which could include for example the apparent higher prevalence of treatment-resistant hypertension and aggressive breast cancers in younger women. It is hoped that these insights will inform prevention and treatment strategies and will enable researchers across academia and industry to discover and develop new medicines to address the specific needs of African patients.
The open lab will directly support the training and education of African scientific researchers who will participate in a portfolio of projects, building local expertise, creating a new generation of African NCD experts while instilling a deep vein of ‘African thinking’ within GSK’s own R&D organisation.
Forming innovative partnerships to transform medicines supply in Africa
Over the next five years, GSK will look to partner with a number of African countries to develop domestic manufacturing capacity and capability. This will see GSK invest up to £100m to expand its existing manufacturing capability in Nigeria and Kenya and build up to five new factories in Africa. The company is currently reviewing possible locations in countries including Rwanda, Ghana and Ethiopia and the selected sites will be announced in due course and subject to Government agreement.
The new facilities will be built to globally recognised good manufacturing practice (GMP) standards and will make locally relevant products such as antibiotics and respiratory and HIV medicines (on behalf of ViiV Healthcare). The initial focus will be on secondary manufacture with the aim to transfer the technology, skills and knowledge needed to enable the local manufacture of more complex products over time. The factories will create a network of localised industry and local employment for a highly skilled workforce drawn from surrounding communities.
To support the scale-up of domestic manufacturing and supply, GSK will establish up to 25 academic Chairs at local African universities in related areas such as pharmaceutical sciences, public health, engineering and logistics. These roles will facilitate the development of new courses as well as internships and student exchanges, and will be pivotal to ensuring manufacturing capability is locked into the continent to help attract further manufacturing investment.
GSK is also taking steps to improve and simplify its supply chain with the creation of regional supply hubs that will help to reduce stock shortages and local supply partnerships to enable more GSK products and medicines to reach under-served rural communities in Africa. These steps will help reduce Africa’s reliance on imported medicines, improving the security of supply and reducing production costs and transportation which in time should help contribute to lower prices.
Creating a tailored portfolio of medicines to address Africa-specific health needs GSK will also optimise its portfolio of medicines for NCDs by working in collaboration with its local partner, Aspen, and with regulators to increase the registration of medicines and vaccines in its existing portfolio, such as its Amoxil antibiotic and its Ventolin respiratory medicine, where not already available.
At the same time, the company continues to work to develop new products designed to meet the specific needs of Africa, for example through its ongoing work with partners to develop the world’s first vaccine against malaria and to create new nutritional products fortified with micro-nutrients to tackle childhood malnourishment.
Playing a part in strengthening healthcare systems
GSK will also increase its support for community health worker training, in recognition of the vital role they play in delivering basic healthcare to many communities. As part of its initiative to reinvest 20% of any profits generated in LDCs back into strengthening healthcare infrastructure in those countries, GSK is already supporting the training of 15,000 healthcare workers with its NGO partners by the end of 2014.
GSK’s commitment to healthcare worker training will now be expanded to include low- and middle-income countries in sub-Saharan Africa. Over the next three years, GSK will partner with charities to help train and upskill 10,000 community healthcare workers across Kenya, Ghana and Nigeria under the umbrella of the One Million Community Health Worker campaign, a UN-led initiative directed by Professor Jeffrey Sachs. The investment will be targeted at supporting the most remote and marginalised communities to help address healthcare inequalities that exist even in fast-growing countries.
These changes build on steps taken by GSK over the past six years to modernise its business model and help improve access to medicines in developing countries. This has seen the company cap the prices of its patented medicines at no more than 25% of developed world prices and reinvest 20% of any profit made back into training healthcare workers in the world’s poorest countries and pursue open innovation models for diseases of the developing world.
Leading economists, financial experts and industry stakeholders have described the Dangote Group’s investments as major drivers of industrialisation and economic transformation across Nigeria and Africa.
The experts cited the Group’s impact on job creation, import substitution, foreign exchange conservation and economic competitiveness.
They voiced their thoughts at the Lagos Economic Summit themed “The Real Deal: Africa’s Greatest Investment Opportunity,” where they urged governments to implement policies that strengthen local industries and accelerate economic diversification.
President and Chief Executive Officer of the Africa Finance Corporation (AFC), Samaila Zubairu, commended the Dangote Group’s sustained investments across Africa, describing them as critical to unlocking the continent’s economic potential.
He noted that while recent economic reforms have improved foreign exchange stability, strengthened reserves and eased inflationary pressures, the focus must now shift to growth in industry, productivity and employment.
READ ALSO: NMDPRA Shares July Domestic Cooking Gas Supply Details
Also speaking, Chief Executive Officer of the Centre for the Promotion of Private Enterprise (CPPE), Muda Yusuf, said industrialisation remains the most effective path to sustainable economic development.
He called for better alignment of trade and industrial policies, stressing that local manufacturers require strategic support to compete effectively and drive broader economic benefits.
Founder and CEO of Nairametrics, Ugodre Obi-Chukwu, said Africa’s growing population presents a significant industrial opportunity, noting that investments such as the Dangote Refinery are helping to retain capital within the continent while strengthening local production capacity.
In his keynote address, Managing Director of Financial Derivatives Company Limited, Bismarck Rewane, said Nigeria is gradually transitioning from a consumption-led economy to one driven by investment and production.
He added that sustained investments in productive sectors will continue to stimulate growth, create jobs and improve living standards.
Participants at the summit also advocated stronger credit infrastructure, improved national identification systems and increased investment in skills development to enhance the productivity and global competitiveness of Africa’s growing youth population.
Photo Caption: From Left – Chief Economist, Dangote Industries Limited, Dr. Hassan Mahmud; Lady Maiden Alex-Ibru; Chairman of Occasion/Special Guest of Honour, Samaila Zubairu; Key Note Speaker Session 1, Bismarck Rewane; during the Real Deal: Africa’s Greatest Investment Opportunity, Sponsored by Dangote Industry Limited in Lagos on Thursday 3, September 2026.
Social media critic Martins Vincent Otse, popularly known as VeryDarkMan (VDM), has released what he described as his first piece of evidence after the Nigeria Police Force challenged him to substantiate his allegations that some police officers allegedly collaborate with kidnappers.
VDM released a video on his Instagram handle on Thursday, August 27, 2026, shortly after the police invited him to provide evidence supporting the claims he made at the 66th Annual General Conference of the Nigerian Bar Association (NBA) in Port Harcourt.
SEE MORE: ‘Provide Evidence’ — Police React to VDM’s Explosive Kidnap Allegation
The activist captioned the video: “My evidence number 1.”
Recalled that VDM, who was a panellist at the NBA conference on Tuesday, had alleged that some police officers manning checkpoints along major highways provide kidnappers and bandits with information about travellers.
According to him, the officers allegedly relay details about the identities and movements of travellers to criminal groups, thereby facilitating abductions for ransom.
The allegation triggered a response from the Nigeria Police Force, which denied the claim and challenged VDM to substantiate his allegations.
The police invitation came as the force sought evidence to support the serious claims made by the social media critic.
In response, VDM released the video, describing it as his “evidence number 1”, signalling that he may provide further material to support his allegations.
The development has continued to attract attention, with the controversy placing renewed focus on allegations of possible collaboration between security personnel and criminal groups involved in kidnapping and banditry.
A former Permanent Secretary of the Federal Civil Service Commission, Goke Adeboroye, has questioned how an alleged fake presidential agency was able to gain access to government facilities, budgetary provisions and office space without being detected.
Adeboroye spoke on Channels Television’s Inside Sources following the discovery of the alleged Presidential Foreign Intervention Promotion Council by the Independent Corrupt Practices and Other Related Offences Commission.
SEE MORE: $1m Extortion Scheme: Fake EFCC Officials Arrested In Plot Against Former NPA MD
The ICPC had said the purported agency had no legal basis and operated with forged appointment letters and other official documents.
The commission also said its alleged Director-General, Adeniyi Matthew, was never appointed by the Federal Government.
The anti-corruption agency further disclosed that its investigation into the PFIPC led to the discovery of the National Brands Development and Made in Nigeria Special Project Office, which it alleged was operating within the Office of the Secretary to the Government of the Federation without proper authorisation.
Reacting to the development, Adeboroye described the situation as a major failure of the government’s bureaucratic system.
“The exposure of that fake presidential agency is a major lapse to say that somebody can actually come into the system, get in on the budget, get offices, and all of that,” he said.
The former permanent secretary identified weaknesses in the bureaucratic structures supporting key offices in the Presidency, including the Office of the Secretary to the Government of the Federation, the Office of the Chief of Staff to the President and the Office of the Head of the Civil Service.
According to him, the bureaucracy in these offices should be strong enough to support the President’s policies while also ensuring that fraudulent or unlawful directives do not gain effect.
“The bureaucracy in those offices are not strong enough to be able to help the President drive the vision at the speed and with the efficiency that he wants,” Adeboroye said.
He also stressed the importance of having professional and experienced civil servants who can scrutinise directives issued by political office holders.
Adeboroye said civil servants should be able to recognise suspicious communications purportedly coming from the Presidency because they are familiar with the official channels through which presidential approvals are transmitted.
“Whether the person brings fake or whatever, you as the civil servant should be trained to be able to detect what should be a genuine communication from the State House. You work in that system,” he said.
He explained that presidential approvals usually pass through established channels involving senior government officials.
“When the President approves anything, he always minutes to about three people. He goes to the Chief of Staff, he goes to SGF, and if he has something to do with civil service, the Head of Service will have it.”
Adeboroye recalled an incident from his time as Permanent Secretary in the Ministry of Interior involving a former governor who claimed to have presidential approval for a diplomatic passport.
He said the then Comptroller-General of the Nigeria Immigration Service, Ude, cross-checked the purported approval before taking action and subsequently sought clarification on whether the former governor, who was no longer in office, should receive the diplomatic passport.
“That’s somebody using the experience of the system to ensure that you are not outplayed,” he said.
The former permanent secretary said similar verification could have been carried out in the alleged fake agency case through a simple phone call to the relevant government offices.
“So we would have expected that on a simple phone call, when I was working in the office of Ekaite, Secretary of Government, I could pick a phone, call any minister, call this, it’s just a phone call from the office of whoever to say, Chief of Staff, is this true? And that would have actually corrected it,” he said.
Meanwhile, the controversy surrounding the National Brands Development and Made in Nigeria Special Project Office has continued.
The chairman of the project office, Musa Aliyu, had alleged that the office was allocated space within the OSGF premises without presidential authorisation.
However, the National Coordinator and Executive Director of the project office, George Nwabueze, denied the allegation, insisting that the office is a project office under the OSGF and has existed for 16 years.
Nwabueze also produced an appointment letter purportedly issued by the OSGF, conveying approval of his appointment as National Coordinator/Executive Director of the Made in Nigeria Project Office.
The conflicting claims have continued to raise questions about the authorisation and status of the project office and the alleged involvement of public officials in its operations.
Petrol Imports Surge 989% to N952bn Amid Dangote, Importers Feud
Abuja Building Collapses Hours After FCTA Sealing
‘Everybody Will Have Stakes’ — Dangote Unveils Refinery IPO
NNPC Ltd Disowns Truck Laden with Cannabis Apprehended by NDLEA
New NSCDC Boss Takes Charge in Osun, Promises Stronger Security
Trump’s Family Unveils New Cryptocurrency Platform
Senate Denies Receiving Petitions Against Tinubu’s Ambassadorial Nominees
Dangote Cement Lights Up Benue Host Communities With CSR Initiatives
Reps Recommend 3-year Jail Term For Aviation minister
Tems Sets New Record On Billboard Hot 100 Chart
